Long-term treatment costs and cost-effectiveness of restoration repair versus replacement

被引:7
|
作者
Kanzow, Philipp [1 ]
Krois, Joachim [2 ]
Wiegand, Annette [1 ]
Schwendicke, Falk [2 ]
机构
[1] Univ Med Ctr Gottingen, Dept Prevent Dent Periodontol & Cariol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Charite Univ Med Berlin, Dept Oral Diagnost Digital Hlth & Hlth Serv Res, Berlin, Germany
关键词
Composite materials; Cost-effectiveness; Minimally invasive dentistry; Restoration repair; Restorative dentistry; Treatment costs; POSTERIOR COMPOSITE RESTORATIONS; LONGEVITY; MOLARS; CARE;
D O I
10.1016/j.dental.2021.02.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives. When managing partially defective restorations, dentists can choose between repair and replacement. We aimed to assess the long-term treatment costs of repairs and replacements. Methods. Partially defective anterior and posterior composite restorations in permanent teeth had been repaired or replaced in a German university hospital and were retrospectively followed until censoring or one of the following events: (1) Extraction, (2) Major complications including placement of indirect restorations, endodontic treatments and extractions, or (3) Any complications including major complications and further direct restorations. Costs were estimated from a German mixed public-private-payer perspective. Cost-effectiveness differences were described using median-based incremental-cost-effectiveness ratios (ICERMEDIAN). Statistical analysis was performed using generalized linear mixed modeling (GLM), Chi(2)-test, and Wilcoxon rank-sum test (p < 0.05). Results. A total of 616 repairs in 468 patients (follow-up: 4.9 +/- 4.1 years) and 264 replacements in 218 patients (follow-up: 4.8 +/- 4.3) were included. While replacements were associated with higher initial treatment costs, median annualized treatment costs did not significantly differ between repair (47.58 Euro [IQR: 24.41-107.04]) and replacement (50.64 Euro [IQR: 26.30-118.78]; p > 0.05), but were higher for molars (75.53 Euro [IQR: 24.41-92.18]) than incisors (45.03 Euro [IQR: 28.19-168.50]; p = 0.011). The difference in the % of extractions, major and any complications were minimal between both groups. The mean ICERMEDIAN of replacement vs. repair was -146.8 Euro/% when extractions were considered as outcomes. Regarding major and any complications, mean ICERMEDIAN amounted to 67.6 Euro/% and 23.9Euro/%, respectively. Significance. Repairs and replacements of partially defective restorations showed similar long-term costs and cost-effectiveness. (C) 2021 The Academy of Dental Materials. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E375 / E381
页数:7
相关论文
共 50 条
  • [1] Long-term cost and cost-effectiveness of mitral valve repair versus replacement
    Thourani, VH
    Zhao, LP
    Chen, EP
    Deaton, C
    Lewis, C
    Anderson, D
    Hitchcock, M
    Murrah, N
    Weintraub, WS
    CIRCULATION, 2004, 110 (17) : 590 - 590
  • [2] Cost and cost-effectiveness of mitral valve replacement versus repair
    Weintraub, WS
    CIRCULATION, 2004, 109 (20) : E235 - E235
  • [3] LONG-TERM COST-EFFECTIVENESS OF EUROFIT VERSUS WAITING LIST
    Finch, A. P.
    Wyke, S.
    Kolovos, S.
    van der Ploeg, H.
    van Nassau, F.
    Bosmans, J. E.
    VALUE IN HEALTH, 2018, 21 : S453 - S453
  • [4] COST-EFFECTIVENESS OF DIAGNOSIS: FROM TESTS TO LONG-TERM OUTCOMES AND COSTS
    Faria, R.
    Soares, M.
    Spackman, E.
    Ahmed, H.
    Brown, L.
    Rs, Kaplan
    Emberton, M.
    Sculpher, M.
    VALUE IN HEALTH, 2017, 20 (09) : A405 - A406
  • [5] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
  • [6] Cost-effectiveness analysis in long-term treatment of risk factors
    Szucs, TD
    Gutzwiller, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (49) : 1958 - 1964
  • [7] Long-term cost-effectiveness of rimonabant in Germany
    Pirk, O.
    Hessel, F.
    Kotowa, W.
    Hertel, N.
    VALUE IN HEALTH, 2007, 10 (06) : A414 - A415
  • [8] LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION
    Touchette, D.
    Boyer, N.
    Atlas, S. J.
    Agboola, F. O.
    Talon, B.
    Schultz, B.
    Kumar, V. M.
    Fazioli, K.
    Fluetsch, N.
    Rind, D.
    VALUE IN HEALTH, 2019, 22 : S683 - S683
  • [9] Expanding the evidence base for the cost-effectiveness of long-term psychoanalytic treatment
    Zevalkink, Jolien
    Berghout, Caspar C.
    JOURNAL OF THE AMERICAN PSYCHOANALYTIC ASSOCIATION, 2006, 54 (04) : 1313 - 1319
  • [10] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336